Odisha News In English

Prameya English, Prameyanews.com, Odisha Latest News, Odisha News Online

Covaxin for 2-18 yrs: Centre examining expert committee recommendations

30/11/2021 at 7:07 PM

New Delhi, Nov, 30: The Centre is examining the recommendation of the Subject Expert Committee (SEC) for grant of market authorization of Covaxin for the age group of 2 to 18 years for restricted use in emergency situation subject to various conditions.

This recommendation is being examined and additional information has been requested at the level of Central Drugs Standard Control Organisation (CDSCO).

CDSCO has also approved COVID-19 vaccine (ZyCoV-D) of M/s Cadila Healthcare for restricted use in emergency situation in the age group 12 years and above.

The Union Minister of State for Health and Family Welfare, Dr Bharati Pravin Pawar stated this in a written reply in the Rajya Sabha.

   Related Posts